# Jiangsu Grand Xinyi Pharmaceutical Co., Ltd · 66-66 · CHINA — FDA import alert red lists: firms subject to detention without physical examination For Jiangsu Grand Xinyi Pharmaceutical Co., Ltd · 66-66 · CHINA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is CHINA; product is Progesterone (17 alpha-hydroxy-6alpha-methylpregn-4-ene-3;20-dione); product code is 65 J - - 31 Progesterone (Progestin); date published is 11/21/2014; address is Coastal Industrial Park, Binhai County , Chen Li Road; Binhuaizhen Binhaixian , Yancheng, Jiangsu CHINA, verified against its source on 2026-09-16. - **Firm:** Jiangsu Grand Xinyi Pharmaceutical Co., Ltd _(verified: appears in the quote below)_ - **Import alert:** 66-66 - **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122" - **Country:** CHINA _(verified: appears in the quote below)_ - **Address:** Coastal Industrial Park, Binhai County , Chen Li Road; Binhuaizhen Binhaixian , Yancheng, Jiangsu CHINA _(verified: appears in the quote below)_ - **Date published:** 11/21/2014 _(verified: appears in the quote below)_ - **Product code:** 65 J - - 31 Progesterone (Progestin) _(verified: appears in the quote below)_ - **Product:** Progesterone (17 alpha-hydroxy-6alpha-methylpregn-4-ene-3;20-dione) _(verified: appears in the quote below)_ ## What the source says > Jiangsu Grand Xinyi Pharmaceutical Co., Ltd Date Published : 11/21/2014 Coastal Industrial Park, Binhai County , Chen Li Road; Binhuaizhen Binhaixian , Yancheng, Jiangsu CHINA 65 J - - 31 Progesterone (Progestin) Date Published: 11/21/2014 Desc: Progesterone (17 alpha-hydroxy-6alpha-methylpregn-4-ene-3;20-dione) ## Source - https://www.accessdata.fda.gov/cms_ia/importalert_202.html Last verified: 2026-09-16. Review by: 2026-11-15. Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).